ID23184A - Garam-garam peptida bpc dengan aktivitas organoprotektif proses pembuatan dan penggunaannya dalam terapi - Google Patents

Garam-garam peptida bpc dengan aktivitas organoprotektif proses pembuatan dan penggunaannya dalam terapi

Info

Publication number
ID23184A
ID23184A IDW991444A ID991444A ID23184A ID 23184 A ID23184 A ID 23184A ID W991444 A IDW991444 A ID W991444A ID 991444 A ID991444 A ID 991444A ID 23184 A ID23184 A ID 23184A
Authority
ID
Indonesia
Prior art keywords
organoprotective
sales
activities
therapy
making
Prior art date
Application number
IDW991444A
Other languages
English (en)
Inventor
Predrag Sikiric
Marijan Petek
Sven Seiwerth
Branko Turkovic
Zeljko Grabarevic
Ivo Rotkvic
Stjepan Mise
Marko Duvnjak
Ivan Udovicic
Original Assignee
Predrag Sikiric Cs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Predrag Sikiric Cs filed Critical Predrag Sikiric Cs
Publication of ID23184A publication Critical patent/ID23184A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Psychology (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IDW991444A 1997-05-23 1998-05-20 Garam-garam peptida bpc dengan aktivitas organoprotektif proses pembuatan dan penggunaannya dalam terapi ID23184A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97108384 1997-05-23

Publications (1)

Publication Number Publication Date
ID23184A true ID23184A (id) 2000-03-23

Family

ID=8226822

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991444A ID23184A (id) 1997-05-23 1998-05-20 Garam-garam peptida bpc dengan aktivitas organoprotektif proses pembuatan dan penggunaannya dalam terapi

Country Status (28)

Country Link
US (1) US6288028B1 (id)
EP (1) EP0983300B1 (id)
JP (1) JP3492381B2 (id)
KR (1) KR100488038B1 (id)
CN (1) CN1166683C (id)
AR (1) AR011478A1 (id)
AT (1) ATE277948T1 (id)
AU (1) AU731317B2 (id)
BG (1) BG64023B1 (id)
BR (1) BR9809457B1 (id)
CA (1) CA2290739C (id)
CZ (1) CZ299423B6 (id)
DE (1) DE69826653T2 (id)
DK (1) DK0983300T3 (id)
EA (1) EA002058B1 (id)
ES (1) ES2229507T3 (id)
HU (1) HU227800B1 (id)
ID (1) ID23184A (id)
IL (2) IL132884A0 (id)
NO (1) NO321126B1 (id)
NZ (1) NZ501323A (id)
PL (1) PL193790B1 (id)
PT (1) PT983300E (id)
RS (1) RS49733B (id)
SK (1) SK159599A3 (id)
TR (1) TR199902866T2 (id)
UA (1) UA61955C2 (id)
WO (1) WO1998052973A1 (id)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005082389A1 (ja) * 2004-02-27 2005-09-09 Fuji Oil Company, Limited 癌転移抑制組成物
US8022216B2 (en) * 2007-10-17 2011-09-20 Wyeth Llc Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
SI24318A (sl) 2013-03-13 2014-09-30 Diagen D.O.O. Nove stabilne soli pentadekapeptida, postopek za njihovo pripravo, njihova uporaba za izdelavo farmacevtskih pripravkov in njihova uporaba v terapiji
US10350293B2 (en) * 2016-08-23 2019-07-16 Pharmacotherapia d.o.o. Compositions and methods for treating symptoms associated with multiple sclerosis
PL3474820T3 (pl) 2017-08-24 2024-05-13 Novo Nordisk A/S Kompozycje glp-1 i ich zastosowania
EP4106724A1 (en) 2020-02-18 2022-12-28 Novo Nordisk A/S Glp-1 compositions and uses thereof
US11065298B1 (en) * 2020-04-24 2021-07-20 Chanda Zaveri Compositions and methods for treating or preventing viral infections
US11833189B1 (en) * 2023-05-15 2023-12-05 Red Mountain Med Spa, LLC Sublingual Semaglutide-BPC 157 combination for weight loss

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2591875B2 (ja) * 1990-09-11 1997-03-19 プレドラグ シキリク 薬理学的活性物質ｂｐｃ、その製造方法及びこれを治療に使用する方法
DK0572688T3 (da) * 1992-05-30 1997-12-01 Sikiric Predrag Peptider, med organ-beskyttende aktivitet, fremgangsmåde til deres fremstilling og deres anvendelse ved terapi
ES2114170T3 (es) * 1992-11-16 1998-05-16 Petek Marijan Peptidos con actividad organo-protectora, su procedimiento de preparacion y su utilizacion en la terapia.

Also Published As

Publication number Publication date
DE69826653D1 (de) 2004-11-04
NO995692L (no) 2000-01-24
CN1257510A (zh) 2000-06-21
BG103905A (en) 2000-07-31
HU227800B1 (en) 2012-03-28
UA61955C2 (en) 2003-12-15
ES2229507T3 (es) 2005-04-16
AU731317B2 (en) 2001-03-29
PL193790B1 (pl) 2007-03-30
IL132884A (en) 2007-08-19
BR9809457A (pt) 2000-06-20
NZ501323A (en) 2001-04-27
KR20010012895A (ko) 2001-02-26
JP3492381B2 (ja) 2004-02-03
PT983300E (pt) 2005-02-28
EP0983300A1 (en) 2000-03-08
BG64023B1 (bg) 2003-10-31
CZ9904142A3 (cs) 2002-03-13
YU60199A (sh) 2002-09-19
EA002058B1 (ru) 2001-12-24
RS49733B (sr) 2008-04-04
DE69826653T2 (de) 2006-03-09
NO321126B1 (no) 2006-03-20
EP0983300B1 (en) 2004-09-29
AR011478A1 (es) 2000-08-16
WO1998052973A1 (en) 1998-11-26
HUP0002329A3 (en) 2001-03-28
NO995692D0 (no) 1999-11-19
US6288028B1 (en) 2001-09-11
EA199901061A1 (ru) 2000-06-26
ATE277948T1 (de) 2004-10-15
PL336897A1 (en) 2000-07-17
IL132884A0 (en) 2001-03-19
JP2000515558A (ja) 2000-11-21
CZ299423B6 (cs) 2008-07-23
HUP0002329A1 (hu) 2000-12-28
AU7914198A (en) 1998-12-11
CA2290739C (en) 2007-06-26
BR9809457B1 (pt) 2010-11-30
CN1166683C (zh) 2004-09-15
DK0983300T3 (da) 2005-01-31
SK159599A3 (en) 2000-11-07
KR100488038B1 (ko) 2005-05-09
TR199902866T2 (xx) 2000-02-21
CA2290739A1 (en) 1998-11-26

Similar Documents

Publication Publication Date Title
ATE198050T1 (de) Therapeutische anwendungen von bpi-protein- produkten zur behandlung von humaner meningococcämia
NL300258I2 (nl) Farmaceutische samenstelling voor toepassing in debehandeling van.
DK0910647T3 (da) Human DNase i hyperaktive varianter
ATE349428T1 (de) Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen
ATE399553T1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
DE59905954D1 (de) Dialkylfumarate zur behandlung von autoimmunerkrankungen
TR200201094T2 (tr) Farmasötik maddeler olarak bisiklik amino asitler
DE69918687D1 (de) 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen
CY1109868T1 (el) Cd81 πρωτεϊνη υποδοχεας ηπατιτιδας c
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
EE04055B1 (et) Ühendid ja kompositsioonid seriinproteaasse, eriti trüptaasse aktiivsusega seotud haiguste raviks, ja nende kasutamine
ID23184A (id) Garam-garam peptida bpc dengan aktivitas organoprotektif proses pembuatan dan penggunaannya dalam terapi
IT1290781B1 (it) Agente attivo terapeutico per il trattamento di malattie degenerative neuronali.
TR200100637T2 (tr) Yeni doğal ürün türevleri
DE69939075D1 (de) Pharmazeutische Zusammenstellung zur Vorbeugung und Behandlung von mit Zellkrankheiten des Augenhintergrundes zusammenhängenden Krankheiten
DE69822297D1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
DE69832722D1 (de) L-threonat-eisen, pharmazeutische zusammensetzung und verwendung zur verbesserung und behandlung von anämie bei menschen
ATE238796T1 (de) Nukleosidderivative in kombinationspräparaten zur behandlung von hsv krankheiten
DE69816808D1 (de) Somatostatin agoniste zur reduzierung von körpergewicht
DE69739190D1 (de) Arzneimittel zur behandlung von oculären kreislauferkrankungen
ES2191825T3 (es) Sales metalicas de acidos biliares con accion fisiologica y su uso en terapia.
DE69813354T2 (de) Mittel zur Behandlung von Herzkrankheiten
GB9723824D0 (en) Cytostatic agents
ES2181160T3 (es) Derivados de 1,4-dihidropiridina y su utilizacion en terapia.